HIV/AIDS Archives -

A Yale University study has found ibalizumab reduced viral replication and increased the count of immune cells in

HIV drug cuts viral load, boosts immunity in Yale study

https://pharmaphorum.com/news/ibalizumab-cuts-hiv-viral-load/

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant

Study indicates potential breakthrough HIV drug

https://pharmaphorum.com/news/study-indicates-breakthrough-hiv/

French biotech to step up clinical development of ABX464.

AbiVax claims progress towards HIV cure

https://pharmaphorum.com/news/abivax-aims-hiv-cure-new-antiretroviral-pill/

Trial involves generics supplied by Mylan.

Landmark HIV prophylaxis trial to begin next month

https://pharmaphorum.com/news/hiv-prophylaxis-trial/

Vosevi is aimed at tough to treat patients.

Gilead’s latest hep C combo approved in US

https://pharmaphorum.com/news/gileads-latest-hep-c-combo-approved-us/

Growth elsewhere will soak up impact of US competitor, says Sir Andrew Witty.

Stop obsessing about generic Advair, says GSK’s Witty

https://pharmaphorum.com/news/stop-obsessing-generic-advair-says-gsks-witty/

The service will provide a live helpdesk for expectant mothers.

Facebook chatbot to help pregnant women in South Africa

https://pharmaphorum.com/news/south-africas-maternal-health-network-momconnect-launches-messenger-bot/

Decision branded “shameful” by HIV campaigners.

NHS refuses to fund HIV prophylaxis – again

https://pharmaphorum.com/news/nhs-refuses-to-fund-hiv-prophylaxis-again/

HIV/AIDS